Development of enzyme replacement therapy for metabolic disease propionic acidemia

被引：0
|
作者：
Damavandi, M. D. [1 ]
Kang, T. S. [1 ]
机构：
[1] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore
来源：
FEBS JOURNAL | 2012年 / 279卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：340 / 340
页数：1
相关论文
共 50 条
  • [41] Enzyme-replacement therapy for metabolic storage disorders
    Brady, RO
    Schiffmann, R
    LANCET NEUROLOGY, 2004, 3 (12): : 752 - 756
  • [42] ADENO-ASSOCIATED VIRUS GENE THERAPY FOR PROPIONIC ACIDEMIA
    Jurgensen, Jacqulyn
    Mudrick, Haley
    McGlinch, Erin
    Barry, Michael
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (03) : 60 - 61
  • [43] Development of enzyme replacement therapy for Fabry disease with a modified α-N-acetylgalactosaminidase
    Sakuraba, Hitoshi
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : S92 - S92
  • [44] Development of enzyme replacement therapy for Farber disease and other disorders with ceramide storage
    Schuchman, Edward H.
    Galanin, Ivan
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : S94 - S94
  • [45] Variability in the clinical presentation of Pompe disease: development following enzyme replacement therapy
    Ley-Martos, Myriam
    Salado-Reyes, Maria J.
    Espinosa-Rosso, Raul
    Solera-Garcia, Jesus
    Jimenez-Jimenez, Luis
    REVISTA DE NEUROLOGIA, 2015, 61 (09) : 416 - 420
  • [46] Development of a signs and symptoms outcome measure for caregivers of patients with methylmalonic acidemia and propionic acidemia (MMAPAQ)
    Sikirica, Vanja
    Schwartz, Ethan J.
    Vockley, Jerry
    Stagni, Kathy
    Bellenger, M. Alex
    Banerjee, Geetanjoli
    Durgam, Neha
    Moshkovich, Olga
    MOLECULAR GENETICS AND METABOLISM, 2024, 143 (1-2)
  • [47] Effect of chemically induced propionic acidemia on neurobehavioral development of rats
    Brusque, AM
    Mello, CF
    Buchanan, DN
    Terracciano, ST
    Rocha, MP
    Vargas, CR
    Wannmacher, CMD
    Wajner, M
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1999, 64 (03) : 529 - 534
  • [48] Dysregulated miRNAs and their pathogenic implications for the neurometabolic disease propionic acidemia
    Ana Rivera-Barahona
    Alejandro Fulgencio-Covián
    Celia Pérez-Cerdá
    Ricardo Ramos
    Michael A. Barry
    Magdalena Ugarte
    Belén Pérez
    Eva Richard
    Lourdes R Desviat
    Scientific Reports, 7
  • [49] Dysregulated miRNAs and their pathogenic implications for the neurometabolic disease propionic acidemia
    Rivera-Barahona, Ana
    Fulgencio-Covian, Alejandro
    Perez-Cerda, Celia
    Ramos, Ricardo
    Barry, Michael A.
    Ugarte, Magdalena
    Perez, Belen
    Richard, Eva
    Desviat, Lourdes R.
    SCIENTIFIC REPORTS, 2017, 7
  • [50] Interruption in enzyme replacement therapy for Gaucher disease
    Weinreb, NJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (04) : 1087 - 1088
12345